Drug Research
Artificial enzyme: Protein designed entirely from scratch functions in cells as a life-sustaining catalyst
A dawning field of research, artificial biology, is working toward creating a genuinely new organism. At Princeton, chemistry professor Michael Hecht and the researchers in his lab are designing and building proteins that can fold and mimic the chemical...
Drug Research
Elligo Health Research Launches Novel IntElligo Research Stack Clinical Technology
Elligo Health Research, an integrated research organization (IRO), announces the launch of its innovative IntElligo Research Stack™ clinical technology. This standards-based technology platform, which powers the System of Accelerated Research (SOAR™) model, will be launched this...
Drug Research
CALIXAR enters into collaboration with BIOTEM for the development of therapeutic antibodies against membrane targets
BIOTEM, a key player in the development of monoclonal antibodies of excellence, is pleased to announce the launch of a collaboration with CALIXAR, an innovative company specialized in the isolation and production of native and functional membrane proteins (MP)....
Articles
Why AI in Drug Discovery has Yet to Live Up to its Promise!
Being a life sciences researcher today involves being inundated with data from every direction. Every day, new studies are published, conferences held, and experiments conducted.
Despite rumours the age of the ‘blockbuster’ drug might be over, we’re currently seeing record...
Drug Research
Development of biologics: The market requires short development times and high productivity
Biologics offer new therapy options for numerous diseases: They are already used to treat cancer and autoimmune diseases such as rheumatoid arthritis as useful alternatives to standard therapies. The extent of their market potential is revealed...
Drug Research
OPTIMA pharma started a cooperation with Charité and the Berlin Institute of Health
Optima Pharma and Charité – Universitätsmedizin Berlin are developing a concept for the automated production and filling of cell and gene therapeutics. These new types of medications are considered a promising new therapy opportunity for incurable...
Articles
Addressing the challenges of BYOD: is the industry over cautious?
Over recent years, the rise of Electronic Clinical Outcome Assessments (eCOA) solutions has opened up a host of opportunities to researchers.
By allowing participants to easily submit information during a clinical trial via devices such as tablets, computers, handheld devices and...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read